Rebif and Dynacirc drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Rebif (interferon beta-1a) and Dynacirc (isradipine). Common drug interactions include hepatic enzyme increased among females and asthma among males.

The phase IV clinical study analyzes what interactions people have when they take Rebif and Dynacirc. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Rebif?

Rebif has active ingredients of interferon beta-1a. It is often used in multiple sclerosis. eHealthMe is studying from 61,126 Rebif users. Check the latest studies of Rebif.

What is Dynacirc?

Dynacirc has active ingredients of isradipine. eHealthMe is studying from 975 Dynacirc users. Check the latest studies of Dynacirc.

On Jul, 19, 2026

12 people who take Rebif and Dynacirc together, and have interactions are studied.

What are the common drug interactions of Rebif and Dynacirc, by gender? *:

female:

Hepatic enzyme increased
Breast cancer in situ
Colitis ischaemic (due to infection of intestine impaired blood supply to colon)
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Foot deformity (functional disability of foot)
Gastrointestinal infection (infection of stomach and intestine)
Hepatic steatosis (fatty liver disease)
Localised infection (infection at the single location)
Osteomyelitis (infection of bone)
Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)

male:

Asthma
Central nervous system lesion (an abnormality in tissue of brain or spinal cord)
Nasopharyngitis (inflammation of the nasopharynx)
Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Nervousness
Pain
Pain in jaw
Skin hypertrophy (skin cells enlarges)
Skin induration (an abnormally hard spot or area on the skin)
Umbilical hernia (an outward bulging (protrusion) of the abdominal lining or part of the abdominal organ(s) through the area around the belly button)

What are the common drug interactions of Rebif and Dynacirc, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Asthma
Central nervous system lesion (an abnormality in tissue of brain or spinal cord)
Depression
Extremity contracture (permanent shortening of a muscle or joint of arms and legs)
Fatigue (feeling of tiredness)
Hallucination (an experience involving the perception of something not present)
Joint contracture (a permanent shortening of a muscle or joint)
Joint stiffness
Memory impairment
Mobility decreased (ability to move is reduced)

40-49:

n/a

50-59:

Ulcer
Abasia (inability to walk)
Arthritis infective (purulent invasion of a joint by an infectious agent which produces arthritis)
Blood disorder
Breast cancer
Glycosylated haemoglobin increased
Headache (pain in head)
Hepatic pain (pain in liver)
Loss of consciousness
Post procedural infection

60+:

Colitis ischaemic (due to infection of intestine impaired blood supply to colon)
Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)

What are the existing conditions these people have? *

High Blood Pressure: 2 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Rebif and Dynacirc?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously